Karo Pharma AB (publ)
Limited financial coverage for KARBF.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Karo Pharma AB (publ) focuses on the development and commercialization of both prescription pharmaceuticals and consumer healthcare products. These offerings are distributed to pharmacies and various retail outlets across numerous international markets, including Sweden, Norway, Denmark, Finland, France, Germany, Italy, other European nations, and the United States. The company's diverse portfolio spans several key areas.
- CEO
- Christoffer Lorenzen
- IPO
- 2013
- Employees
- 225
- HQ
- Stockholm, SE
Get TickerSpark's AI analysis on KARBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $5.71
- 52W Low
- $5.25
- 50D MA
- $5.25
- 200D MA
- $5.25
- Beta
- 0.00
- RSI (14)
- 0
- Avg Volume
- 0
No earnings-call transcripts are available for KARBF yet.
- Free Float
- 0.0%
- Shares Outstanding
- 289.68M
- Float Shares
- 0
Our KARBF coverage
Recent articles, reports, and earnings notes.
No research on KARBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KARBF report →